Validation using clinical samples from Tianjin Chest Hospital confirmed that KIF2C expression levels were significantly higher in tumor tissues compared with matched adjacent non-cancerous tissues, as determined by quantitative PCR (Figure 9b). The gene discussed is KIF2C; the disease is neoplasm.